Revista Brasileira de Epidemiologia (Brazilian Journal of Epidemiology) - BJE (Rev. bras. epidemiol.) - every four months, journal published by the ABRASCO - aims at publishing not previously published Original Articles, including critical reviews on specific themes, which may contribute to the development of Epidemiology and related Sciences.
Revista also publishes articles in the following categories: Debate aimed at discussing different views of the same theme which may be presented as an original article followed by comments from other authors, reproduction of panels and other similar formats; Brief communications: short reports of the original research results, besides news on events held in the field, book reviews, and others; Letters to the Editor - comments from readers on articles published in Revista Brasileira de Epidemiologia.
Its abbreviated title is Rev. bras. epidemiol., and it should be used in bibliographies, footnotes, references and bibliographic strips.
The articles published in Revista Brasileira de Epidemiologia (Brazilian Journal of Epidemiology) are indexed or summarized by:
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
Associação Brasileira de Saúde Coletiva (ABRASCO)
Faculdade de Saúde Pública / Universidade de São Paulo (FSP/USP)
Secretaria de Vigilância em Saúde (SVS) e Ministério da Saúde (MS)
Organização Pan-Americana da Saúde (OMS/OPAS)
Scope and general informations
Revista Brasileira de Epidemiologia (RBE) [Brazilian Journal of Epidemiology] is a scientific journal published by the Brazilian Public Health Association [Associação Brasileira de Saúde Coletiva] (www.abrasco.org.br). Its first edition was published in 1998, and since then the journal has maintained the continuous and regular publication of original articles of high scientific merit, which contribute with the advancement of knowledge and the development of Epidemiology and its related sciences.
Articles published by the RBE are under the BY-CC Creative Commons license. Thus, the copy, adjustment, remixing, and redistribution of the material in any format and by any means, clearly indicating the eventual performed changes, is allowed. Authorship and publication credits should be properly presented, as well as the license link. When the authors publish their article in the RBE, they transfer their copyrights to the journal and grant it with the first publication right.
Ethics and transparency policies
RBE follows the guidelines of ethics and transparency established in the document: Principles of Transparency and Best Practice in Scholarly Publishing, published by the Committee on Publication Ethics (COPE), by the Directory of open Access Journals (DOAJ), by the Open Access Scholarly Publishers Association (OASPA) and by the World Association of Medical Editors (WAME). The full document is available at: https://doi.org/10.24318/cope.2019.1.12.
Approval by the Ethics Committee in Research (CEP)
All papers submitted to the RBE must have followed the recommendations of ethics in research of Declaration of Helsinki and the standards contained in the Resolutions No. 466/2012 and 510/2016 from the Brazilian Health Office (CNS, acronym in Portuguese). The approval by an Ethics Committee in Research (CEP, acronym in Portuguese) is not required for studies that analyze added data and data without people’s identification, such as those available in public domain databases. No instance is above the CEP to analyze the nature of investigation proposals, following the orientation of the Brazilian Commission of Ethics in Research, CNS, Brazilian Department of Health (CONEP/CNS/MS). The CEP that approves the investigation should be registered at the CONEP.
Submission of the CEP protocol copy is mandatory at the submission.
The RBE supports the policies from the World Health Organization (WHO) and International Committee of Medical Journal Editors (ICMJE) for registration of clinical trials. Thus, it recognizes the importance of these initiatives for international registration and disclosure of open-access information. Therefore, only articles of clinical trials that have received an identification number in one of the clinical trials validated for the criteria established by the WHO and ICMJE, whose addresses are available at the ICMJE website, are accepted for publication. The identification/approval number should be registered in the title page.
The entities that register clinical trials according to ICMJE criteria are:
For definition of article authorship, the RBE follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals elaborated by the International Committee of Medical Journal Editors (ICMJE). The authors should follow the guidelines available at http://www.icmje.org/
In its protocols, RBE incorporates strict guidelines to prevent and identify possible research misconduct. In case any sign of misconduct is identified in a study submitted to the journal, the Editors-in-chief follow COPE’s guidelines to handle the situation.
RBE encourages authors to make the raw data of their studies publicly available, as well as the routines used in data analyses. In the case of intervention studies, the data must be freely available, or at request, always in anonymity.
Policy of the peer review process
The peer review process is a vital stage of the article’s editorial process, so RBE handles it carefully. At the same time, the journal understands that agility, in an editorial process, is extremely important both for the authors and the scientific community. Therefore, RBE always aims at providing analyses with ethics, maximum scientific rigor and agility. In that sense, the following stages are determined:
All manuscripts are analyzed for the identification of plagiarism through appropriate softwares.
Regarding peer review, RBE reinforces the need for the strict observance of ethical requirements for reviewers, elaborated by the Committee on Publication Ethics, available at: https://publicationethics.org/files/Ethical_Guidelines_For_Peer_Reviewers_2.pdf
Editors and reviewers of Revista Brasileira de Epidemiologia, along with the authors who publish in the journal, must always comply with the guidelines regarding Sex and Gender Equity in Research (SAGER). The SAGER guidelines include a set of orientations that guide the report of information on sex and gender in the study design, the data analysis and the result and interpretation of findings, as described in English at https://www.equator-network.org/reporting-guidelines/sager-guidelines/.
Besides, RBE observes the gender equity policy in the composition of its body of editors and reviewers.
Types of manuscripts accepted
The RBE receives manuscripts in the following categories:
The words count includes Introduction, Methods, Results, and Discussion (title page, abstract, references, tables, and figures are not included in this count).
The presented manuscripts should be solely directed to the RBE, and its simultaneous presentation in another journal is not allowed. Information and concepts present in the articles, as well as the veracity of research content, are the authors’ entire responsibility.
Presentation of the manuscripts
Manuscripts are accepted in Portuguese, Spanish or English. Articles in Portuguese and Spanish shall be followed by an abstract in the original text language, besides an abstract written in English. The articles in English shall be followed by the abstract, besides the abstract written in Portuguese.
The title page shall include:
In the following pages, always beginning in a new page, the following sections should be presented:
Abstracts shall have 250 words at most and shall be presented in the structured form, including the sections: Objective, Methods, Results, and Conclusion.
The last paragraph(s) of the Discussion is(are) recommended to be focused on the conclusions and recommendations.
They should be numbered according to the first time it is mention in the text, using superscripted Arabic algorisms. The final list shall follow the text number order and ignore the authors’ alphabetical order of the authors. Titles of books, publishers or others should not be abbreviated. Titles of journals shall follow the abbreviations in the Index Medicus/Medline Index. They should include the names of the first six authors; but if there are more than six authors, the expression et al. must come after the names. Whenever it is available, the digital object identifier (DOI) shall be reported in the end of the reference, based on the following example. Personal communications, new or ongoing papers may be quoted when completely required, but they should not be included in the list of references. They should only be presented in the text body or in a footnote. When an article is still going to be published, the journal title, year and other available data should be provided, followed by the expression "In press” in parenthesis. The accuracy of the references is the authors’ responsibility.
Examples of references
Barros AJ, Victora CG. Measuring coverage in MNCH: determining and interpreting inequalities in coverage of maternal, newborn, and child health interventions. PLoS Med 2013; 10: e1001390. https://doi.org/10.1371/journal.pmed.1001390
Books and other monographs
Congress paper or similar (published)
Report of the World Health Organization
Figures and tables
Illustrations may have 15 cm at most of width in the Portrait format and 24 cm of width in the Landscape format and be presented within the requested margin (configuration named by Word as “Regular”). Colored figures are accepted. Photos may be provided in high resolution; graphs in editable format; tables, equations, charts and flowcharts should always be sent in an editable file (Word or Excel), but never in image.
Conflict of interests
Scientific writing guidelines
The full final file (title page, sections, references, and illustrations) shall be submitted only in the DOC ou DOCX format (Microsoft Word).
Mailing address: Av. Dr. Arnaldo, 715 - BIBLIOTECA - 2º andar - sala 03 - 01246-904 - Cerqueira César - São Paulo -SP – Brasil
Telephone/Fax Number: +55 11 3085–5411
Website: www.scielo.br/rbepidElectronic mail address: firstname.lastname@example.org